The rapid influenza diagnostic test (RIDT) market is estimated to reach at a value of US$ 1,121.5 Mn by the end of 2022 and expected to reach at a value of US$ 1,930.7 Mn by 2030 with a significant CAGR of 7.1%.
Reports and Insights (R&I) has published a new report titled, “Rapid Influenza Diagnostic Test (RIDT) Market: Opportunity Analysis and Future Assessment 2022-2030”
Global Rapid Influenza Diagnostic Test (RIDT) Market, By Product (RIDTs for Influenza A, RIDTs for Influenza B), By End-User (Hospitals, Clinical Laboratories, Other End-User), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030.
The rapid influenza diagnostic test (RIDT) market is estimated to reach at a value of US$ 1,121.5 Mn by the end of 2022 and expected to reach at a value of US$ 1,930.7 Mn by 2030 with a significant CAGR of 7.1%.
As per the report, the rising count of benefits offered by rapid influenza diagnostic test (RIDT) across the world such as quick access to the result in lesser than around 15 minutes, and is easy to perform, is majorly contributing to the growth of the global rapid influenza diagnostic test (RIDT) market.
Rapid influenza diagnostic tests (RIDTs) are immunoassays which offer to detect the existence of influenza A and B viral nucleoprotein allergens in respiratory samples. The most important and common reason for morbidity and mortality among the population is regarded as influenza. As such, the need for use and development of diagnostics aimed at decreasing consecutive health and economic impacts appear.
The growth in the number of geriatric population and rising incidences of influenza-associated with it as old people are considered more vulnerable to the influenza virus, across the world is projected to augment the growth of the global rapid influenza diagnostic test (RIDT) market.
In addition, growth in the number of government programs to encounter the rising influenza outbreaks across the globe is expected to propel the growth of the global rapid influenza diagnostic test (RIDT) market over the forthcoming years.
Moreover, the recent technological developments in the manufacturing of advanced and innovative rapid influenza diagnostic tests are also projected to act as a major driving factor for the growth of the rapid influenza diagnostic test (RIDT) market across the globe.
In addition to that, the rise in the incidence of severe disorders such as diabetes and cardiovascular disease across the world also increases the possibilities of a count of people suffering from influenza, thereby giving a positive push to the growth of the global rapid influenza diagnostic test (RIDT) market.
Furthermore, the accelerated growth in healthcare expenditure concentrating towards R&D of influenza diagnosis and therapeutics is expected to aamplify the growth of the global rapid influenza diagnostic test (RIDT) market.
Reports and Insights Study identifies some of the key participating players in the Rapid Influenza Diagnostic Test (RIDT) Market globally are Thermo Fisher Scientific, Roche Diagnostics, Alere Inc., Quidel Corporation, Becton, Dickinson and Company, DiaSorin, SA Scientific Ltd., Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser AG), and Luminex Corporation.
About Reports and Insights:
Reports and Insights (R&I) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us
Reports and Insights
Tel: +1-(718)-312-8686
For Sales Query: [email protected]
For New Topics & Other Info: [email protected]
Website: https://reportsandinsights.com